DumanRSHeningerGRNestlerEJ. A molecular and cellular theory of depression. Arch Gen Psychiatry1997;54:597–606,
2.
PlotskyPMOwensMJNemeroffCB. Psychoneuroendocrinology of depression: Hypothalamic–pituitary–adrenal axis. Psychoneuroendocrinology1998;21:293–307.
3.
BardenNReulMHMHolsboerF. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?Trends Neurosci1995;18:6–11.
4.
ShelineYlWangPOGadoMHCsemanskyJGVannierM W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA1996;93:3908–13.
5.
GreenlundLJSDeckwerthTLJohnsonEM. Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death. Neuron1995;14:303–15.
6.
CvijicGRadojicicRDjordjevicJDavidovicV. The effect of glucocorticoids, on the activity of monoamine oxidase, copper-zinc superoxide dismutase and catalase in the rat hypothalamus. Funct Neurol1995;10:175–81.
7.
LiX-MChlan-FoumeyJJuorioAVBennettVLShrikhandeSBowenRO. Antidepressants upregulate mRNA levels of the neuroprotective enzyme superoxide dismutase. J Psychiatry Neurosci2000;25:43–7.
8.
LacikaSCooperJP. Pulmonary embolus possibly associated with clozapine treatment [letter]. Can J Psychiatry1999;44:396–7.
9.
ClardyJGaleRH. Mortality risk and clozapine [letter]. Am J Psychiatry1995;152:651.
10.
WalkerAMLanzaLLArellanoFRothmanKJ. Mortality in current and former users of clozapine. Epidemiology1997;8:671–7.
11.
LindstromLH. The effect of long-term treatment with clozapine in schizophrenia: A retrospective study in 96 patients treated with clozapine for up to 13 years. Acta Psychiatr Scand1988;77:524–9.
12.
BaumePCantorCHRolfeA. Cybersuicide: The role of interactive suicide notes on the Internet. Crisis1997;18:73–9.
13.
BaumePRolfeAClintonM. Suicide on the Internet: A focus for nursing intervention. Australian and New Zealand Journal of Mental Health Nursing1998;7:134–41.
14.
AlaoAOYollesJCArmentaW. Cybersuicide: The Internet and suicide. Am J Psychiatry1999;156:1836–7.
15.
GottfriesCGRoosBE. Man's emotional capacity – an unexplored an unexploited possibility. Med Hypotheses1993;43:347–55.
16.
ScrivenM. Hard-won lessons in program evaluation. New Dir Program Eval1993;58:1–107.
17.
DixonJ. Evaluation criteria in studies of continuing education in the health professions: A critical review and a suggested strategy. Eval Health Prof1978;1:47–65.
18.
DavisDTaylor-VaiseyA. Two decades of Dixon: The question(s) of evaluating continuing education in the health professions. J Cont Educ Health Prof1997;17:207–13.
19.
Jennet PA, and others. Chart stimulated recall: A method for assessing factors which influence physicians' practice performance. International Conference Proceedings Approaches to the Assessment of Clinical Competence Part 2, Dundee Scotland September 1992.
20.
JennetPAffleckL. Chart audit and chart stimulated recall as methods of needs assessment in continuing professional health education. J Cont Educ Health Prof1998;18:163–71.
21.
JennetP. Chart stimulated recall: A technique to assess clinical competence and performance. Ed for Gen Practice1995;6:30–4.
22.
Jennet P, and others. Patient charts and physician office management decisions: Chart audit and chart stimulated recall. J Cont Educ Health Prof1995;15:31–9.
23.
DavisDFoxR. The physician as learner: Linking research to practice. Chicago: AMA Press; 1994.
24.
RosofABFelchWC. Continuing medical education: A primer. 2nd ed.Westport (CT): Praeger Publishers; 1992.
25.
PowellRAGeeTL. The effects of hypnosis on the features of dissociative identity disorder: A reexamination of the evidence. Can J Psychiatry1999;44:914–6.
26.
RossCANortonGR. Effects of hypnosis on the features of multiple personality disorder. Am J Clin Hypn1989;32:99–106.
27.
WhalenJENashMR. Hypnosis and dissociation: Theoretical, empirical, and clinical perspectives. In: MichelsonLKRayWJ, editors. Handbook of dissociation. Theoretical, empirical, and clinical perspectives. New York: Plenum Press; 1996. p 191–206.
28.
BorisonRLArvanitisLA, Miller BG, Study-Group. ICI 204,636, an atypical antipsychotic: Efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. J Clin Psychopharmacol1996;16:158–69.
29.
Wolters ECh. Dopaminomimetic psychosis in Parkinson's disease patients: Diagnosis and treatment. Neurology1999;52(3 Suppl):S10–S13.
30.
CapgrasJReboul-LachauxJ. L'illusion des “sosies” dans un délire systématisé chronique. Bull Soc Clin Med Ment1923;11:6–16.
31.
SignerSF. Capgras' syndrome: The delusion of substitution. J Clin Psychiatry1987;48:147–50.
32.
SilvaJALeongGBShanerAL. A classification system for misidentification syndromes. Psychopathology1990;23:27–32.